Bank of New York Mellon’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.68M | Buy |
|
|||||
|
2025
Q2 | $5.47M | Buy |
|
|||||
|
2025
Q1 | $4.57M | Buy |
|
|||||
|
2024
Q4 | $5.75M | Sell |
|
|||||
|
2024
Q3 | $6.1M | Sell |
|
|||||
|
2024
Q2 | $7.96M | Buy |
|
|||||
|
2024
Q1 | $8.79M | Buy |
|
|||||
|
2023
Q4 | $8.22M | Buy |
|
|||||
|
2023
Q3 | $4.85M | Buy |
|
|||||
|
2023
Q2 | $4.46M | Buy |
|
|||||
|
2023
Q1 | $3.53M | Buy |
|
|||||
|
2022
Q4 | $3.9M | Buy |
|
|||||
|
2022
Q3 | $5.36M | Buy |
|
|||||
|
2022
Q2 | $3.25M | Buy |
|
|||||
|
2022
Q1 | $2.68M | Buy |
|
|||||
|
2021
Q4 | $6.29M | Buy |
|
|||||
|
2021
Q3 | $2.39M | Buy |
|
|||||
|
2021
Q2 | $2.68M | Buy |
|